← Leaderboards
Monica T Hinds
Oregon Health & Science University
$9,084,363
Attributed
$16,460,691
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,460,691 · 7
By mechanism
R01$16,460,691 · 7
Top collaborators
- Owen J Mccarty8 shared
- Evelyn King Fai Yim6 shared
- Dusan Pavcnik4 shared
- Jeremy Goldman3 shared
- Joseph E Aslan2 shared
- Lakshmi Prasad Dasi2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Owen J McCarty$13,437,961
- Dusan Pavcnik$757,003
- William Messer$6,360,195
- Jorge Enrique Tolosa$1,418,308
- Evelyn King Fai Yim$1,628,769
Others in their field
Top investigators on “Surface”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$207,726,216
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$118,664,913
Research focus
SurfaceIn VivoIn VitroThrombosisPreventBloodThrombusBlood PlateletsBlood VesselsDesignBlood FlowCoagulation ProcessGrowthStentsAnticoagulantsResponseDevicesAnimal ModelTranslatingFibrinImplantBiochemicalPolymersNonhuman Primate
Grant awards (27)
Contact Pathway Activation on Vascular Devices$721,378
R01 · FY2025 · HL
Biodegradable Metal Stent Alloys for Vascular Applications$706,962
R01 · FY2025 · HL · contact PI
Patient-specific blood cell reactivity and flow dynamic profiles in transcatheter aortic valve replacement$675,924
R01 · FY2025 · HL · contact PI
Engineering of biomaterials with controlled biomolecule delivery for cardiovascular applications$608,613
R01 · FY2025 · HL · contact PI
Contact Pathway Activation on Vascular Devices$706,951
R01 · FY2024 · HL
Patient-specific blood cell reactivity and flow dynamic profiles in transcatheter aortic valve replacement$703,868
R01 · FY2024 · HL · contact PI
Biodegradable Metal Stent Alloys for Vascular Applications$697,849
R01 · FY2024 · HL · contact PI
Engineering of biomaterials with controlled biomolecule delivery for cardiovascular applications$647,359
R01 · FY2024 · HL · contact PI
Biodegradable Metal Stent Alloys for Vascular Applications$729,969
R01 · FY2023 · HL · contact PI
Contact Pathway Activation on Vascular Devices$721,378
R01 · FY2023 · HL
Contact Pathway Activation on Vascular Devices$762,385
R01 · FY2022 · HL
Contact Pathway Activation on Vascular Devices$743,402
R01 · FY2021 · HL
Contact Pathway Activation on Vascular Devices$757,040
R01 · FY2020 · HL
Contact Pathway Activation on Vascular Devices$770,140
R01 · FY2019 · HL
Surface Modification Compliant Vascular Grafts$738,265
R01 · FY2019 · HL · contact PI
Contact Pathway Activation on Vascular Devices$823,936
R01 · FY2018 · HL
Surface Modification Compliant Vascular Grafts$634,210
R01 · FY2018 · HL · contact PI
Surface Modification Compliant Vascular Grafts$12,343
R01 · FY2018 · HL · contact PI
Surface Modification Compliant Vascular Grafts$622,390
R01 · FY2017 · HL · contact PI
Surface Modification Compliant Vascular Grafts$602,971
R01 · FY2016 · HL · contact PI
Modified surfaces to capture endothelial progenitor cells for venous applications$373,527
R01 · FY2014 · HL · contact PI
Modified surfaces to capture endothelial progenitor cells for venous applications$362,855
R01 · FY2013 · HL · contact PI
Vascular tissue engineering: rational design using modeling$592,913
R01 · FY2012 · HL · contact PI
Modified surfaces to capture endothelial progenitor cells for venous applications$381,150
R01 · FY2012 · HL · contact PI
Vascular tissue engineering: rational design using modeling$592,913
R01 · FY2011 · HL · contact PI
Modified surfaces to capture endothelial progenitor cells for venous applications$385,000
R01 · FY2011 · HL · contact PI
Modified surfaces to capture endothelial progenitor cells for venous applications$385,000
R01 · FY2010 · HL · contact PI